Jane Street
CERO

Jane Street’s CERo Therapeutics CERO Stock Holding History

Jane Street’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29
Closed -$3.45K – 10841
2024
Q4 		$3.45K Buy
29
+1
+4% +$233 ﹤0.01% 9231
2024
Q3 		$5.32K Buy
28
+12
+75% +$3.66K ﹤0.01% 9398
2024
Q2 		$9.58K Buy
16
+3
+23% +$6.97K ﹤0.01% 9111
2024
Q1 		$81.4K Buy
+13
New +$145K ﹤0.01% 8602

Other funds holding CERO

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jane Street's CERO Position: Q1 2025 in Review

Jane Street sold out of CERo Therapeutics (CERO) in Q1 2025, closing a stake of 29 shares — an estimated $3.45K sold.

Jane Street first reported a position in CERO in Q1 2024 and held it in 4 quarters. The position peaked at $81.4K in Q1 2024. 13 funds tracked by Wall St. Rank hold CERO as of Q1 2025.

  • Jane Street reported no remaining CERo Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 29 CERo Therapeutics shares in Q1 2025, an estimated $3.45K.
  • Jane Street first reported a position in CERo Therapeutics in Q1 2024 and held it in 4 quarters.
  • Jane Street's CERo Therapeutics position peaked at $81.4K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.